MedTrace Logo

Medication Adherence in Children Who Had a Liver Transplant

NCT01154075 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2017-12-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate the use of a novel method to measure adherence to immunosuppressant medications in predicting rejection episodes in children who had a liver transplant.

Conditions

  • Pediatric Recipients of a Liver Transplant

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER

  • University of Pittsburgh

    collaborator OTHER

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Icahn School of Medicine at Mount Sinai

    lead OTHER

Principal Investigators

  • Eyal Shemesh, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01154075 on ClinicalTrials.gov